KLOW Research Blend

KLOW Research Blend is an advanced four-peptide formulation combining BPC-157, TB-500, GHK-Cu and KPV in one research product. It is designed for controlled laboratory studies involving cellular signalling, inflammatory-response mechanisms, extracellular-matrix activity and tissue-remodelling pathways.

BPC-157, TB-500 and GHK-Cu have been investigated mainly through laboratory and preclinical research, while reliable human clinical evidence remains limited.

What’s Included

• BPC-157: Studied in cellular and tissue-response models
• TB-500: Associated with thymosin beta-4 fragment and actin-related research
• GHK-Cu: A copper-binding peptide studied in cellular signalling and extracellular-matrix activity
• KPV: A synthetic tripeptide investigated in inflammatory-response research

Product Features

• Advanced four-peptide research blend
• Convenient combined laboratory formulation
• Suitable for controlled analytical and comparative studies
• Supplied in securely sealed and clearly labelled packaging
• Intended for handling by qualified research professionals

Storage

Store under the conditions stated on the product label or certificate of analysis. Keep the container securely sealed and protected from excessive heat, moisture and direct sunlight.

Important Notice

KLOW is a product-specific blend name and is not an FDA-approved medicine. The FDA reports limited or absent human safety information for BPC-157, TB-500, injectable GHK-Cu and KPV, along with potential concerns involving immunogenicity, aggregation, peptide impurities and product characterisation.

This product must not be promoted as a treatment for injuries, inflammation, skin conditions, digestive conditions or any other medical purpose.

For laboratory research purposes only. Not for human or veterinary use. Not intended to diagnose, treat, cure or prevent any disease.